Haemonetics ticks up on 2-for-1 split
Haemonetics launches a 2-for-1 stock split, sending shares up slightly on Wall Street.
The Braintree, Mass.-based blood management company said the split, in the form of a 100% stock dividend for shareholders of record as of Nov. 9, is aimed at boosting its market capitalization.
That's the number of shares multiplied by their price. Before the split, Haemonetics' market cap was about $1.05 billion; post-split, that number jumped to $2.11 billion.